7/29/2026
Ibogaine research faces representation challenges
Psychedelic trials often exclude marginalized groups, raising questions about equity and efficacy.
Topic archive
psychedelic research
4 stories
7/29/2026
Texas initiates ibogaine research with federal support
State-led ibogaine study in Texas gains federal backing, marking a significant research development.
7/24/2026
Trump administration fast-tracks ibogaine research
Psychoactive drug ibogaine gains attention for addiction treatment potential.
7/17/2026
Eli Lilly acquires 5-MeO-DMT developer for $3.8B
Pharmaceutical giant expands into psychedelic research with major acquisition.